Compliance & Validation — Not documented by Atlas
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
Averroes.ai
No-code AI visual inspection platform for automated defect detection in manufacturing.
Averroes.ai, founded in 2021 and headquartered in San Mateo, California, provides a no-code AI visual inspection platform that automates defect detection across manufacturing and industrial processes, including pharmaceutical manufacturing use cases. The company is privately held. Atlas found no vendor-held security certifications documented on its site.
- Headquarters
- San Mateo, United States
- Founded
- 2021
- Deployment options
- cloud, on-premise
- Website
- https://www.averroes.ai
- https://www.linkedin.com/company/averroes-ai-inc
Categories
AI Use Cases
- Manufacturing Quality Control
Vendor Scorecard
50% — Partial coverage. Coverage score — how completely Atlas documents Averroes.ai across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Deployment & Hosting — Documented
cloud, on premise
Pricing Transparency — Not documented by Atlas
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Implementation & Onboarding — Not documented by Atlas
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Organization & Role Fit — Documented
Biotech Startup, Mid-Size Biotech, Large Pharma, IT / Digital, Data Management
Solution Scope — Documented
Manufacturing Quality Control
Company Viability — Partially documented
Founded 2021
Always ask the vendor
Not captured in Atlas data — confirm directly. Excluded from the score above.
Data Rights & IP
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Model Credibility & Explainability
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?
Questions to Ask This Vendor
- Which pharmaceutical inspection defect types has the platform been trained on?
- How much labeled data is required to reach target accuracy for our line?
- How is the model validated and revalidated for a GxP environment?
- What deployment options (cloud vs edge/on-premise) fit our facility constraints?